Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA.

Brodie JD, Figueroa E, Dewey SL.

Synapse. 2003 Dec 1;50(3):261-5. No abstract available.

PMID:
14515344
2.

Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction.

Brodie JD, Figueroa E, Laska EM, Dewey SL.

Synapse. 2005 Feb;55(2):122-5.

PMID:
15543630
3.

Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot results.

Fechtner RD, Khouri AS, Figueroa E, Ramirez M, Federico M, Dewey SL, Brodie JD.

Arch Ophthalmol. 2006 Sep;124(9):1257-62.

PMID:
16966620
4.

A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.

Somoza EC, Winship D, Gorodetzky CW, Lewis D, Ciraulo DA, Galloway GP, Segal SD, Sheehan M, Roache JD, Bickel WK, Jasinski D, Watson DW, Miller SR, Somoza P, Winhusen T.

JAMA Psychiatry. 2013 Jun;70(6):630-7. doi: 10.1001/jamapsychiatry.2013.872.

PMID:
23575810
5.

Visual field and ocular safety during short-term vigabatrin treatment in cocaine abusers.

Berezina TL, Khouri AS, Winship MD, Fechtner RD.

Am J Ophthalmol. 2012 Aug;154(2):326-332.e2. doi: 10.1016/j.ajo.2012.02.026. Epub 2012 Jun 15.

PMID:
22704138
6.

The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat.

Stromberg MF, Mackler SA, Volpicelli JR, O'Brien CP, Dewey SL.

Pharmacol Biochem Behav. 2001 Feb;68(2):291-9.

PMID:
11267634
7.

The potential value of a negative finding: an illustrative example.

Silverman K, DeFulio A, Leoutsakos JM.

JAMA Psychiatry. 2013 Jun;70(6):571-2. doi: 10.1001/jamapsychiatry.2013.1116. No abstract available.

PMID:
23575653
8.

Cocaine withdrawal symptoms predict medication response in cocaine users.

Sofuoglu M, Poling J, Gonzalez G, Gonsai K, Kosten T.

Am J Drug Alcohol Abuse. 2006;32(4):617-27.

PMID:
17127550
9.

[Succinic semialdehyde dehydrogenase deficiency: decrease in 4-OH-butyric acid levels with low doses of vigabatrin].

Escalera GI, Ferrer I, Marina LC, Sala PR, Salomons GS, Jakobs C, Pérez-Cerdá C.

An Pediatr (Barc). 2010 Feb;72(2):128-32. doi: 10.1016/j.anpedi.2009.09.018. Epub 2009 Dec 16. Spanish.

10.

Co-administration of gamma-vinyl GABA and cocaine: preclinical assessment of safety.

Molina PE, Ahmed N, Ajmal M, Dewey S, Volkow N, Fowler J, Abumrad N.

Life Sci. 1999;65(11):1175-82.

PMID:
10503933
11.

Emerging pharmacological strategies in the fight against cocaine addiction.

Sofuoglu M, Kosten TR.

Expert Opin Emerg Drugs. 2006 Mar;11(1):91-8. Review.

PMID:
16503828
12.

New medications for the treatment of cocaine dependence.

Kampman KM.

Ann Ist Super Sanita. 2009;45(2):109-15. Review. No abstract available.

13.

Novel approaches to the treatment of cocaine addiction.

Sofuoglu M, Kosten TR.

CNS Drugs. 2005;19(1):13-25. Review.

PMID:
15651902
14.

Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study.

Gonzalez G, Sevarino K, Sofuoglu M, Poling J, Oliveto A, Gonsai K, George TP, Kosten TR.

Addiction. 2003 Nov;98(11):1625-32.

PMID:
14616189
15.

Vigabatrin improves paroxysmal dystonia in succinic semialdehyde dehydrogenase deficiency.

Leuzzi V, Di Sabato ML, Deodato F, Rizzo C, Boenzi S, Carducci C, Malaspina P, Liberanome C, Dionisi-Vici C.

Neurology. 2007 Apr 17;68(16):1320-1. No abstract available.

PMID:
17438226
16.

[Current pharmacotherapies and immunotherapy in cocaine addiction].

Karila L, Weinstein A, Benyamina A, Coscas S, Leroy C, Noble F, Lowenstein W, Aubin HJ, Lépine JP, Reynaud M.

Presse Med. 2008 Apr;37(4 Pt 2):689-98. Epub 2007 Dec 21. Review. French.

PMID:
18155399
17.

Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial.

Hamilton JD, Nguyen QX, Gerber RM, Rubio NB.

Am J Addict. 2009 Jan-Feb;18(1):48-52. doi: 10.1080/10550490802544318.

PMID:
19219665
18.

Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction.

Roberts DC.

Physiol Behav. 2005 Sep 15;86(1-2):18-20. Review.

PMID:
16061264
19.

Expanding treatment options for cocaine dependence.

Brady KT.

Am J Psychiatry. 2009 Nov;166(11):1209-10. doi: 10.1176/appi.ajp.2009.09091312. No abstract available.

PMID:
19884233
20.

Novel pharmacotherapeutic treatments for cocaine addiction.

Shorter D, Kosten TR.

BMC Med. 2011 Nov 3;9:119. doi: 10.1186/1741-7015-9-119. Review.

Items per page

Supplemental Content

Write to the Help Desk